A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | GLMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3.9 | $280.5 | 2% |
|
| Shares Out (Mil) | 1.0 | 53.9 | 4% |
|
| Institutional Ownership | 62.0% | 92.9% | 39% |
|
| Float (Mil) | 1.0 | 41.9 | 2% |
|
| Beta | 0.67 | 0.94 | 39% |
|
| Avg Daily Volume (000s) | 17 | 480 | 20% |
|
| Price Change (52-week) |
(62.1%) | 59.8% | 11% |
|
| Growth | GLMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 14.1% | na |
|
| Net Income (5yr) | 18.6% | (10.1%) | 71% |
|
| EPS (5yr) | na | 15.8% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 71.1% | (15.6%) | 97% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | GLMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($11) | ($43) | 28% |
|
| EPS (TTM) | ($14.106) | ($1.500) | 4% |
|
| Operating Cash Flow (TTM) (Mil) | ($9) | ($31) | 21% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($7) | $182 | 2% |
|
| Valuation | GLMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.31 | 2.81 | 4% |
|
| P/E | na | 20.2 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | GLMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 66.9% | na |
|
| Net Margin | na | (74.2%) | na |
|
| ROA | (55.0%) | (47.8%) | 11% |
|
| ROE | (68.2%) | (55.0%) | 12% |
|
| Liabilities to Assets | 30.3% | 30.0% | 22% |
|
| F-Score | 1 | 3 | 1% |
|
Galmed Pharmaceuticals Ltd. did not pass any screens on 9/4/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
